Pharm Res. Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction. Angew Chem Int Ed Engl. Tumor-targeted nanomedicines for cancer theranostics. Pharmacol Res. Cancer nanomedicines: oversold or underappreciated? Status and trends in the development of clinical diagnostic agents. Wiley Interdiscip Rev Nanomed Nanobiotechnol. Mesenchymal stem cells can be recruited to wounded tissue via hepatocyte growth factor-loaded biomaterials.
J Tissue Eng Regen Med. Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. Sensitivity and accuracy of hybrid fluorescence-mediated tomography in deep tissue regions. J Biophotonics. Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment. Nano Res. J Vis Exp. Cancer nanomedicine: Is targeting our target? Nat Rev Mater. Targeting cellular and microenvironmental multidrug resistance. Bioconjug Chem. Tailoring the physicochemical properties of core-crosslinked polymeric micelles for pharmaceutical applications.
Radionuclide imaging of liposomal drug delivery. Bone tissue engineering using polyetherketoneketone scaffolds combined with autologous mesenchymal stem cells in a sheep calvarial defect model. J Craniomaxillofac Surg. The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance.
Eur Surg Res. Maximum likelihood positioning algorithm for high-resolution PET scanners. Multiple pathway assessment to predict anti-atherogenic efficacy of drugs targeting macrophages in atherosclerotic plaques. Vascul Pharmacol. Invest Radiol. Polymeric Nanogels with Tailorable Degradation Behavior. Phys Med Biol. Int J Cancer. Nanoparticles for intravascular applications: physicochemical characterization and cytotoxicity testing. Locoregional cancer therapy using polymer-based drug depots.
Drug Discov Today. Comput Phys Commun. Erratum in: Angiogenesis. Establishment of a rat model: Associating liver partition with portal vein ligation for staged hepatectomy. Sonoporation enhances liposome accumulation and penetration in tumors with low EPR. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.
Cancer Lett. Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges. Histidine-rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease. Sci Total Environ. Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer. Endocr Relat Cancer. Refinement of adsorptive coatings for fluorescent riboflavin-receptor-targeted iron oxide nanoparticles. J Am Soc Nephrol. Advances in digital SiPMs and their application in biomedical imaging. Longitudinal imaging of the ageing mouse.
Mechanisms of Ageing and Development. Comparison of three remote radiolabelling methods for long-circulating liposomes. Telomere shortening in enterocytes of patients with uncontrolled acute intestinal graft-versus-host disease. Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery. Distribution of technetiumm PEG-liposomes during oligofructose-induced laminitis development in horses.
Vet J. Role of platelet-derived growth factor-CC in capillary rarefaction in renal fibrosis. Am J Pathol. Chem Rev. Image-guided drug delivery: preclinical applications and clinical translation. Lipocarbazole, an efficient lipid peroxidation inhibitor anchored in the membrane. Bioorg Med Chem. Erythropoietin improves the accumulation and therapeutic effects of carboplatin by enhancing tumor vascularization and perfusion. Applications of nanoparticles for diagnosis and therapy of cancer. Br J Radiol. RGD-decorated conjugated polymer particles as fluorescent biomedical probes prepared by Sonogashira dispersion polymerization.
Chem Commun. Fluorophore labeling of core-crosslinked polymeric micelles for multimodal in vivo and ex vivo optical imaging. Nano Today. Noninvasive molecular ultrasound monitoring of vessel healing after intravascular surgical procedures in a preclinical setup. Bioactive gyroid scaffolds formed by sacrificial templating of nanocellulose and nanochitin hydrogels as instructive platforms for biomimetic tissue engineering.
Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration. Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy. Enhanced in vitro and in vivo cellular imaging with green tea coated water-soluble iron oxide nanocrystals. Adv Funct Mater. Eur J Pharm Biopharm. Water-soluble dopamine-based polymers for photoacoustic imaging.
Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth in vivo. Formulation and characterization of microspheres loaded with imatinib for sustained delivery. Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging. Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases.
Algorithmically generated rodent hepatic vascular trees in arbitrary detail. J Theor Biol. Decationized polyplexes for gene delivery.
Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
Rodent models and imaging techniques to study liver regeneration. Dynamic contrast-enhanced ultrasound parametric maps to evaluate intratumoral vascularization. In-vivo detection of the erythropoietin receptor in tumours using positron emission tomography. Haematopoietic cell-derived Jnk1 is crucial for chronic inflammation and carcinogenesis in an experimental model of liver injury.
J Hepatol. Differential contrast of gold nanorods in dual-band OCT using spectral multiplexing. J Nanopart Res. Nanoparticles for imaging: top or flop? Erratum in: Radiology. Decationized polyplexes as stable and safe carrier systems for improved biodistribution in systemic gene therapy. Absorption reconstruction improves biodistribution assessment of fluorescent nanoprobes using hybrid fluorescence-mediated tomography.
Performance of lead-free versus lead-based hunting ammunition in ballistic soap. Influence of repetitive contrast agent injections on functional and molecular ultrasound measurements. Science to practice: Cellular therapy of Parkinson disease--a new radiotracer to target transplanted dopaminergic cells with PET. The degeneration of biological cardiovascular prostheses under pro-calcific metabolic conditions in a small animal model. Magnetic resonance imaging in zirconia-based dental implantology. Clin Oral Implants Res. Liposomal corticosteroids for the treatment of inflammatory disorders and cancer.
The Theranostic Path to Personalized Nanomedicine. Clin Transl Imaging. Optical tomography of MMP activity allows a sensitive noninvasive characterization of the invasiveness and angiogenesis of SCC xenografts. Absolute MR thermometry using nanocarriers. Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging. Spatio-temporal simulation of first pass drug perfusion in the liver.
PLoS Comput Biol. Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages. MicroRNAp promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med. CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis. PEG-pHPMAm-based polymeric micelles loaded with doxorubicin-prodrugs in combination antitumor therapy with oncolytic vaccinia viruses. Polym Chem. In vitro, in vivo and in silico analysis of the anticancer and estrogen-like activity of guava leaf extracts.
Curr Med Chem. Activation of CXCR7 limits atherosclerosis and improves hyperlipidemia by increasing cholesterol uptake in adipose tissue. Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes. Recent advances in molecular, multimodal and theranostic ultrasound imaging. Micro-CT imaging of tumor angiogenesis: quantitative measures describing micromorphology and vascularization. Nondestructive monitoring of tissue-engineered constructs. Biomed Tech.
Cell type specific interleukin-6 induced responses in tumor keratinocytes and stromal fibroblasts are essential for invasive growth. Tie-breaking in round-robin soccer tournaments and its influence on the autonomy of relative rankings: UEFA vs. FIFA regulations. Eur Sport Manag Q. J Mater Chem B. Multidrug resistance: Physiological principles and nanomedical solutions.
Rhodamine-loaded intercellular adhesion moleculetargeted microbubbles for dual-modality imaging under controlled shear stresses. Circ Cardiovasc Imaging. Science to practice: will contrast agents for molecular imaging of angiogenesis help overcome the limitations of functional vascular imaging?
- The Raven (A Jane Harper Horror Novel).
- Pharmacy Books - Buy Pharmacy Books Online at Best Prices In India | iqegumybiwyf.ml.
- The critical points of a function of n variables.
- Ubuy Saudi Arabia Online Shopping For ares in Affordable Prices..
Ultrasound molecular imaging of E-selectin in tumor vessels using poly n-butyl cyanoacrylate microbubbles covalently coupled to a short targeting peptide. A murine model of stent implantation in the carotid artery for the study of restenosis. Science to Practice: exploring new indications for molecular US imaging. Osteogenesis of heterotopically transplanted mesenchymal stromal cells in rat models of chronic kidney disease.
J Bone Miner Res. Phase shift variance imaging - a new technique for destructive microbubble imaging. Regorafenib inhibits growth, angiogenesis, and metastasis in a highly aggressive, orthotopic colon cancer model. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. Faiss, S. Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors—the International Lanreotide and Interferon Alfa Study Group.
Fazio, N. Feldman, D. The role of vitamin D in reducing cancer risk and progression. Cancer 14, Flaherty, K. Inhibition of mutated, activated BRAF in metastatic melanoma. Foss, F. A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma. Blood , — Fratta, E. Epigenetics of melanoma: implications for immune-based therapies. Immunotherapy 5, — Chemotherapy and chemoprevention by thiazolidinediones.
Biomed Res. Gerner, C. From cutaneous metastasis tob rain metastasis: proteome signatures and functional features of melanoma cells. Giovannelli, P. Targeting rapid action of sex-steroid receptors in breast and prostate cancers. Goldberg, J. Phase I trial of interferon alpha2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma. Cancer 95, — Graham, L. Targeting persistent androgen receptor signaling in castration-resistant prostate cancer.
Hart, C. Biomodulatory metronomic therapy in stage IV melanoma is well-tolerated and may induce prolonged progression-free survival, a phase I trial. Anakoinosis: Communicative reprogramming of tumor systems - for rescuing from chemorefractory neoplasia. Hau, P. Oncology 73, 21— Herold, M. Long-term follow-up of rituximab plus first-line mitoxantrone, chlorambucil, prednisolone and interferon-alpha as maintenance therapy in follicular lymphoma.
Heudobler, D. Biomodulatory metronomic therapy shows remarkable activity in chemorefractory multi-system langerhans cell histiocytosis. Blood Google Scholar. Higurashi, T. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial. Lancet Oncol. Hill, M. Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer. Hnisz, D. Super-enhancers in the control of cell identity and disease.
Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Cell 58, — Huang, J. Dissecting super-enhancer hierarchy based on chromatin interactions. Iland, H.
- Ubuy Egypt Online Shopping For ares in Affordable Prices.;
- The Servant Economy: Where Americas Elite is Sending the Middle Class?
Role of arsenic trioxide in acute promyelocytic leukemia. Options Oncol. Jin, Y. Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myeloma. Katoh, M. WNT signaling pathway and stem cell signaling network. Kelly, J. Kerbel, R. Cancer Lett. Kim, T. Epigenetic therapy in acute myeloid leukemia: current and future directions. Klobuch, S. Biomodulatory treatment with azacitidine, all-trans retinoic acid and pioglitazone induces differentiation of primary AML blasts into neutrophil like cells capable of ROS production and phagocytosis.
Kopetz, S. Koutsilieris, M. Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach. Expert Opin. Drugs 15, — Krilis, M. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
Ophthalmology , — Kulke, M. A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer. Cancer J. Kummar, S. Randomized phase II trial of cyclophosphamide and the oral poly ADP-ribose polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer. New Drugs 34, — Lecarpentier, Y. Lissoni, P. Immunoendocrine therapy with low-dose subcutaneous interleukin-2 plus melatonin of locally advanced or metastatic endocrine tumors.
Oncology 52, — Lo-Coco, F. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy. Mack, S. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling. Mantovani, G. Results of a dose-intense phase 1 study of a combination chemotherapy regimen with cisplatin and epidoxorubicin including medroxyprogesterone acetate and recombinant interleukin-2 in patients with inoperable primary lung cancer.
Masood, R. Kaposi sarcoma is a therapeutic target for vitamin D 3 receptor agonist. Blood 96, — Mayer, R. Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia. Proteomics 17, — McCabe, M. McCarthy, P. Lenalidomide maintenance after autologous stem-cell transplantation in newly diagnosed multiple myeloma: a meta-analysis. McDermott, D. Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma. Meyer, S. Miller, V. Initial clinical trial of a selective retinoid X receptor ligand, LGD Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid.
Mitchell, C. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. Motzer, R. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. Mueller, E. Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. Mulholland, D. Muqaku, B. Multi-omics analysis of serum samples demonstrates reprogramming of organ functions via systemic calcium mobilization and platelet activation in metastatic melanoma.
Proteomics 16, 86— Neelapu, S. Nervi, C. Epigenetic treatment of solid tumours: a review of clinical trials. Epigenetics 7, Nicolini, A. Immunotherapy and hormone-therapy in metastatic breast cancer: a review and an update. Drug Targets 17, — Norsa, A. Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in chemotherapy-pretreated patients with advanced lung adenocarcinoma and low performance status. Cancer Biother. Nourmoussavi, M. Ovarian ablation for premenopausal breast cancer: a review of treatment considerations and the impact of premature menopause.
Cancer Treat. Olokpa, E. Pahler, J. Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response. Neoplasia 10, — Papi, A. Nuclear receptors agonists exert opposing effects on the inflammation dependent survival of breast cancer stem cells. Cell Death Differ. PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models.
Pasquier, E. Effective management of advanced angiosarcoma by the synergistic combination of propranolol and vinblastine-based metronomic chemotherapy: a bench to bedside study.
EBioMedicine 6, Pitteri, S. Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression. Pomerantz, M. Phase II study of low dose and high dose conjugated estrogen for androgen independent prostate cancer. Pramanik, R. Metronomic chemotherapy vs best supportive care in progressive pediatric solid malignant tumors: a randomized clinical trial. JAMA Oncol. Prost, S. Quach, H. Mechanism of action of immunomodulatory drugs IMiDS in multiple myeloma. Leukemia 24, 22— Querfeld, C.
The EPA National Library Catalog | EPA National Library Network | US EPA
Bexarotene in the treatment of cutaneous T-cell lymphoma. Comparison of selective retinoic acid receptor- and retinoic X receptor-mediated efficacy, tolerance, and survival in cutaneous t-cell lymphoma. Reebye, V. Oncogene 37, — Reichle, A. Evolution-Adjusted Tumor Pathophysiology. Dordrecht: Springer. C-reactive protein in patients with metastatic clear cell renal carcinoma: an important biomarker for tumor-associated inflammation. Insights 1, 87— Principles of modular tumor therapy. Control of cancer-associated inflammation and survival: Results from a prospective randomized phase II trial in gastric cancer.
Systems biology: a therapeutic target for tumor therapy. Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial. Melanoma Res. Anti-inflammatory and angiostatic therapy in chemorefractory multisystem Langerhans' cell histiocytosis of adults. Remark, R. Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin.
Richardson, P. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. Rochlitz, C. BMC Cancer Romiti, A. Current achievements and future perspectives of metronomic chemotherapy.
New Drugs 35, — Rosner, M. Human stem cells alter the invasive properties of somatic cells via paracrine activation of mTORC1. Roussel, M. Rousselot, P. Pioglitazone together with imatinib in chronic myeloid leukemia: a proof of concept study. Cancer , — Ryu, S.
San Miguel, J. Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma MM : a randomised, open-label, phase 3 trial. Sanchez, D. Sarker, D. Scharla, S. Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,dihydroxyvitamin D3.
Sciarra, A. Somatostatin analogues and estrogens in the treatment of androgen ablation refractory prostate adenocarcinoma. Senerchia, A. Results of a randomized, prospective clinical trial evaluating metronomic chemotherapy in nonmetastatic patients with high-grade, operable osteosarcomas of the extremities: A report from the Latin American Group of Osteosarcoma Treatment. Sengupta, S.
Super-enhancer-driven transcriptional dependencies in cancer. Sharma, R. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women. Cochrane Database Syst. Antitumor effects of somatostatin analogs in neuroendocrine tumors. Oncologist 17, — Sim, C.
Simkens, L. Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer CAIRO3 : a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group. Simonsson, B. Macbooks All In Ones 2 in 1 Laptops. Home Theaters Headphones. Towels Sink Urinals. Tool Sets Bathroom Accessory Sets. Close to Ceiling Lights Pendant Lights.
Body Lotions Face Creams. Tents Accessories Lights Camping Bed. Billiard Fishing Toss Games. Business Writing Skills. Graphic Novels Comic Strips. My Wishlist. Know about stores. Products of this store will be shipped directly from the US to your country.